-
L Leenhardt,
F Borson-Chazot,
M Calzada,
B Carnaille,
A Charrié,
B Cochand-Priollet,
C Do Cao,
S Leboulleux,
G Le Clech, G Mansour,
F Menegaux,
H Monpeyssen,
J Orgiazzi,
A Rouxel,
J L Sadoul,
M Schlumberger,
J Tramalloni,
F Tranquart,
J L Wemeau
Annales d Endocrinologie 09/2011; 72(4 Suppl 1):H1-26. · 0.74 Impact Factor
-
L Leenhardt,
F Borson-Chazot,
M Calzada,
B Carnaille,
A Charrié,
B Cochand-Priollet,
C D Cao,
S Leboulleux,
G Le Clech, G Mansour,
F Menegaux,
H Monpeyssen,
J Orgiazzi,
A Rouxel,
J L Sadoul,
M Schlumberger,
J Tramalloni,
F Tranquart,
J L Wemeau
[show abstract]
[hide abstract]
ABSTRACT: Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin. American, European and French Recommendations for the treatment of differentiated vesicular thyroid cancer were recently published. Cervical ultrasound scanning is now considered a key examination in the follow-up of these cancers. This examination is noninvasive, easy to perform and to obtain, is not costly, but remains operator-dependent. To date, there are no recommendations published that assemble all the technical aspects, results, indications and the limits of this examination in the initial medical report and the follow-up of these cancers. In order to standardise the procedure and validate the quality of the examination, a workgroup made up of a panel of experts particularly involved in carrying out ultrasound scans was set up. The aim was to draw up a good practice guide for performing cervical ultrasound scans and echo-guided techniques in treating patients with differentiated thyroid cancer of vesicular origin. The main objectives are to: (a) standardise the procedure and reports, (b) define the criteria for establishing whether lesions identified during a cervical ultrasound scan are malignant or benign, (c) standardise the indications for carrying out cytological tests and an in situ assay of markers, (d) help doctors to select the patients who ought to receive a cervical ultrasound scan and or cytological tests, (e) discuss how frequently the examinations should be carried out depending on the risk of recurrence.
Annales d Endocrinologie 06/2011; 72(3):173-97. · 0.74 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The aim of our study was to define the usefulness of fine needle aspiration cytology (FNAC) in the assessment of loco-regional recurrence of differentiated thyroid carcinoma (DTC).
Among 1182 consecutive patients treated and followed for DTC from 1992 to 2001, we retrospectively analysed 65 FNAC results of patients presenting a suspicion of loco-regional recurrence. Recurrences were proved at histology in 35 cases and by cervical radioiodine uptake on post-therapeutic WBS (whole body scan) in nine cases.
Among the 44 recurrences, FNAC results were malignant, benign and unsatisfactory in 33, two and nine cases, respectively. For the diagnosis of malignancy, FNAC sensitivity was 94%, specificity 100%, positive predictive value 100% and negative predictive value 87%. In the 35 cases where divergent results between diagnostic WBS (37-111MBq (131)I) and Tg level were observed, FNAC assessed the final status in 22 cases (malignant and benign in 17 and five cases, respectively). Of the 12 non-functioning and non-secreting lesions, FNAC diagnosed malignancy in four of the five malignant cases and ruled out malignancy in all seven benign lesions.
These results outline the interest of FNAC in the assessment of loco-regional recurrences of DTC, especially when classical follow-up tools such as WBS and/or Tg level are unable to detect the recurrences.
European Journal of Surgical Oncology 05/2005; 31(3):288-93. · 2.50 Impact Factor
